Skip to main content
SpringerLink
Log in

Asymptomatic Hyperthyroidism in Older Adults

Is it a Distinct Clinical and Laboratory Entity?

  • Therapy In Practice
  • Published:
Drugs & Aging Aims and scope Submit manuscript

Abstract

Hyperthyroidism is the result of increased serum free thyroid hormone levels and is associated with a well recognized set of clinical signs and symptoms. However, older patients who develop hyperthyroidism tend to have fewer hyperadrenergic signs and an increased incidence of weight loss, cardiac arrhythmias and, occasionally, apathetic mood. This article highlights the paucity of clinical signs and symptoms of hyperthyroidism in older people and reviews the potential biochemical changes in thyroid hormone physiology that may account for an altered clinical presentation in older people with hyperthyroidism. First, a brief vignette from our own clinical practice is described to highlight an unusual presentation of hyperthyroidism in an older woman. The subject is then reviewed on the basis of relevant articles identified through a MEDLINE search of the English literature, using the key words ‘hyperthyroidism’ and ‘aging’. The available evidence indicates that the clinical syndrome of asymptomatic hyperthyroidism in older adults appears to be distinct from the more widely recognized syndromes of apathetic hyperthyroidism or thyroid hormone resistance. Age-related changes in thyroid hormone economy and reduced cellular uptake of thyroid hormone as well as changes in thyroid hormone regulation of gene expression may account for reduced manifestations of hyperthyroidism in older adults. Thus, in addition to the well known changes in thyroid gland anatomy and function with aging, there may be an age-related resistance to thyroid hormone action. Asymptomatic hyperthyroidism may well be a syndrome that is currently under-diagnosed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Table I
Fig. 1
Table II
Fig. 2
Table III

Similar content being viewed by others

References

  1. Oiknine RF, Mooradian AD. Thyroid disorders. In: Pathy MS, Sinclair AJ, Morley JE, editors. Principles and practice of geriatric medicine. Vol. 2. 4th ed. Chichester: John Wiley and Sons Limited, 2006: 1405–14

    Google Scholar 

  2. Helfand M. Screening for subclinical thyroid dysfunction in non-pregnant adults: a summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med 2004; 140: 128–41

    PubMed  Google Scholar 

  3. Toft A. Subclinical hyperthyroidism. N Engl J Med 2001; 345: 512–6

    Article  PubMed  CAS  Google Scholar 

  4. Diez JJ. Hyperthyroidism in patients older than 55 years: an analysis of the etiology and management. Gerontology 2003; 49: 316–23

    Article  PubMed  Google Scholar 

  5. Samuels MH. Subclinical thyroid disease in the elderly. Thyroid 1998; 8: 803–13

    Article  PubMed  CAS  Google Scholar 

  6. Case CC, Mooradian AD. Thyroid changes with aging. In: Morley JE, Armbrecht HJ, Coe RM, et al., editors. The science of geriatrics: facts. Research and intervention in geriatrics series. Vol. 1. Paris: Serdi Publisher, 2000: 273–81

    Google Scholar 

  7. Mooradian AD, Wong NC. Age-related changes in thyroid hormone action. Eur J Endocrinol 1994; 131: 451–61

    Article  PubMed  CAS  Google Scholar 

  8. Shah GN, Li JP, Schneiderjohn P, et al. Cloning and characterization of a complementary DNA for a thyroid hormone responsive protein in mature rat cerebral tissue. Biochem J 1997; 327: 617–23

    PubMed  CAS  Google Scholar 

  9. Shah GN, Li J, Mooradian AD. Novel translational repressor (NAT-1) expression is modified by thyroid state and age in brain and liver. Eur J Endocrinol 1999; 139: 649–53

    Article  Google Scholar 

  10. Mooradian AD, Li J, Shah GN. Age-related changes in thyroid hormone responsiveness protein (THRP) expression in cerebral tissue of rats. Brain Res 1998; 793: 302–4

    Article  PubMed  CAS  Google Scholar 

  11. Mooradian AD, Scarpace PJ. 3,5,3′-L-triiodothyronine regulation of B-adrenergic receptor density and adenylyl cyclase activity in synaptosomal membranes of aged rats. Neurosci Lett 1993; 161: 101–4

    Article  PubMed  CAS  Google Scholar 

  12. Mooradian AD, Scarpace PJ. The response of isoproterenol- stimulated adenylate cyclase activity after administration of Ltriiodothyronine is reduced in aged rats. Horm Metab Res 1989; 21: 638–9

    Article  PubMed  CAS  Google Scholar 

  13. Mooradian AD. Blood-brain transport of triiodothyronine is reduced in aged rats. Mech Ageing Dev 1990; 52: 141–7

    Article  PubMed  CAS  Google Scholar 

  14. Mooradian AD. The hepatic transcellular transport of 3, 5, 3′-triiodothyronine is reduced in aged rats. Biochim Biophys Acta 1990; 1054: 1–7

    Article  PubMed  CAS  Google Scholar 

  15. Mooradian AD, Fox-Robichaud A, Meijer ME, et al. Relationship between transcription factors and S14 gene expression in response to thyroid hormone and age. Proc Soc Exp Biol Med 1994; 207: 97–101

    PubMed  CAS  Google Scholar 

  16. Mariotti S, Franceschi C, Cosarizza A, et al. The aging thyroid. Endocr Rev 1995; 16: 686–715

    PubMed  CAS  Google Scholar 

  17. Trivalle C, Doucet J, Chassagne P, et al. Differences in the signs and symptoms of hyperthyroidism in older and younger patients. J Am Geriatr Soc 1996; 44: 50–3

    PubMed  CAS  Google Scholar 

  18. Hershman JM, Pekary AE, Berg L, et al. Serum thyrotropin and thyroid hormone levels in elderly and middle-aged euthyroid persons. J Am Geriatr Soc 1993; 41: 823–8

    PubMed  CAS  Google Scholar 

  19. Van Coevorden A, Laurent E, Decoster C, et al. Decreased basal and stimulated thyrotropin secretion in healthy elderly men. J Clin Endocrinol Metab 1989; 69: 177–85

    Article  PubMed  Google Scholar 

  20. Friedman D, Reed RL, Mooradian AD. The prevalence of over medication with levothyroxine in ambulatory elderly patients. Age 1992; 15: 9–13

    Article  Google Scholar 

  21. Ordene KW, Pan C, Barzel US, et al. Variable thyrotropin response to thyrotropin-releasing hormone after small decreases in plasma thyroid hormone concentrations in patients of advanced age. Metabolism 1983; 32: 881–8

    Article  PubMed  CAS  Google Scholar 

  22. Mooradian AD. Normal age-related changes in thyroid hormone economy. Clin Geriatr Med 1995; 11: 159–69

    PubMed  CAS  Google Scholar 

  23. Donda A. Lemarchand-Beraud T. Aging alters the activity of 5′-deiodinase in the adenohypophysis, thyroid gland, and liver of the male rat. Endocrinology 1989; 124: 1305–9

    Article  PubMed  CAS  Google Scholar 

  24. Donda A. Reymond MJ. Zurich MG, et al. Influence of sex and age on T3 receptors and T3 concentration in the pituitary gland of the rat: consequences on TSH secretion. Mol Cell Endocrinol 1987; 54: 29–34

    Article  PubMed  CAS  Google Scholar 

  25. Sundbeck G, Eden S, Jagenburg R, et al. Thyroid dysfunction in 85-year-old men and women: influence of non-thyroidal illness and drug treatment. Acta Endocrinologica 1991; 125: 475–86

    PubMed  CAS  Google Scholar 

  26. Thomas FB, Mazzaferri EL, Skillman TG. Apathetic thyrotoxicosis: a distinctive clinical and laboratory entity. Ann Intern Med 1970; 72: 679–85

    PubMed  CAS  Google Scholar 

  27. Beck-Peccoz P, Mannavola D, Persani L. Syndromes of thyroid hormone resistance. Ann Endocrinol (Paris) 2005; 66: 264–9

    Article  CAS  Google Scholar 

  28. Chatterjee VK. Resistance to thyroid hormone. Horm Res 1997; 48Suppl. 4: 43–6

    Article  PubMed  CAS  Google Scholar 

  29. Beck-Peccoz P, Chatterjee VK. The variable clinical phenotype in thyroid hormone resistance syndrome. Thyroid 1994; 4: 225–32

    Article  PubMed  CAS  Google Scholar 

  30. American Association of Clinical Endocrinologiste Thyroid Task Force. Medical guidelines for clinical practice for the evaluation and treatment of hyperthyroidism and hypothyroidism. Endocr Pract 2002; 8: 457–67

    Google Scholar 

  31. Ladenson PW, Singer PA, Ain KB, et al. American Thyroid Association guidelines for detection of thyroid dysfunction. Arch Intern Med 2000; 160: 1573–5

    Article  PubMed  CAS  Google Scholar 

  32. Surks MI, Ortiz E, Daniels GH, et al. Subclinical thyroid disease: scientific review and guidelines for diagnosis and management. JAMA 2004; 291: 228–38

    Article  PubMed  CAS  Google Scholar 

  33. U.S. Preventive Services Task Force. Screening for thyroid disease: recommendation statement. Ann Intern Med 2004; 140: 125–7

    Google Scholar 

  34. Biondi B, Palmieri EA, Lombardi G, et al. Effects of subclinical thyroid dysfunction on the heart. Ann Intern Med 2002; 137: 904–14

    PubMed  Google Scholar 

  35. Foldes J, Tarjan G, Szathmari M, et al. BMD in patients with endogenous subclinical hyperthyroidism: is this thyroid status a risk factor for osteoporosis? Clin Endocrinol 1993; 39: 521–7

    Article  CAS  Google Scholar 

  36. Sawin CT, Geller A, Wolf PA, et al. Low serum thyrotropin concentrations as a risk factor for atrial fibrillation in older persons. N Engl J Med 1994; 331: 1249–52

    Article  PubMed  CAS  Google Scholar 

  37. Cooper DS, Goldminz D, Levin AA, et al. Agranulocytosis associated with antithyroid drugs: effects of patient age and drug dose. Ann Intern Med 1983; 98: 26–9

    PubMed  CAS  Google Scholar 

  38. Surks MI, Sievert R. Drugs and thyroid function. N Engl J Med 1995; 333: 1688–94

    Article  PubMed  CAS  Google Scholar 

  39. Mooradian AD, Korenman SG. Endocrinology. In: Braunwald E, editor. Atlas of internal medicine. 3rd ed. Philadelphia (PA): Springer, 2007: 121–79

    Google Scholar 

  40. Clinical guidelines part 1: screening for thyroid disease. American College of Physicians. Ann Intern Med 1998; 129: 141–3

    Google Scholar 

Download references

Acknowledgements

No sources of funding were used to assist in the preparation of this article. The author has no conflicts of interest that are directly relevant to the content of this article.

Author information

Authors and Affiliations

  1. Department of Medicine, University of Florida College of Medicine, 653-1 West 8th Street, 4th Floor - LRC, Jacksonville, Florida, 32209, USA

    Arshag D. Mooradian

Authors
  1. Arshag D. Mooradian
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Arshag D. Mooradian.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mooradian, A.D. Asymptomatic Hyperthyroidism in Older Adults. Drugs Aging 25, 371–380 (2008). https://doi.org/10.2165/00002512-200825050-00002

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00002512-200825050-00002

Keywords

Search

Navigation